Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03701646 · ClinicalTrials.gov registry record
ClearSight Validation in Pediatrics
A clinical trial, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 10
- Enrollment target
NCT03701646: Completed study, sponsored by Nemours Children's Clinic.
NCT03701646 is a clinical trial that has completed, run by Nemours Children's Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03701646 has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Specific aim 1: The specific aim of this study is to compare cardiac output measurements as well as cardiac index, and stroke volume obtained via thermodilution during a cardiac catheterization with data obtained by the ClearSight cardiac output monitoring system. Specific aim 2: To compare arterial blood pressure measurements obtained by arterial line with arterial waveform measurements obtained by the ClearSight System. The hypothesis is: Cardiac output measurements or arterial blood pressure measurements taken non-invasively with the ClearSight system in pediatric patients who are either undergoing cardiac catheterization or have an arterial line will correlate with cardiac output measurements taken by pulmonary artery catheter thermodilution or arterial pressures measured by an arterial line.
Primary Outcome
Comparison of measurements obtained by the ClearSight device compared to the invasive measurements will be used to evaluate whether the ClearSight device has any validity in pediatrics.
Interventions
- DEVICE Measurement by Clearsight device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-11-02 |
| Est. Completion | 2019-06-01 |
What the finished NCT03701646 record still lists
NCT03701646 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Measurement by Clearsight device is the first listed.
NCT03701646 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03701646 about?
NCT03701646 is a clinical study titled "ClearSight Validation in Pediatrics". Specific aim 1: The specific aim of this study is to compare cardiac output measurements as well as cardiac index, and stroke volume obtained via thermodilution during a cardiac catheterization with data obtained by the ClearSight cardiac output monitoring system. Specific aim 2: To compare arterial...
What is the current status of trial NCT03701646?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2017-11-02. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT03701646?
The interventions under investigation include: Measurement by Clearsight device (DEVICE).
Who is sponsoring clinical trial NCT03701646?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI